Cargando…

An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders

Treatment of haematological disorders in patients with chronic hepatitis B or resolved infection (anti-HBc-positive) is associated with a risk of hepatitis B reactivation. Moreover, patients with chronic hepatitis C have a higher risk of haematological malignancies than general population. An electr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riveiro-Barciela, Mar, Gubern, Paula, Roade, Luisa, Abrisqueta, Pau, Carreras, María José, Farriols, Anna, Bosch, Francesc, Esteban, Rafael, Buti, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033156/ https://www.ncbi.nlm.nih.gov/pubmed/32080253 http://dx.doi.org/10.1038/s41598-020-59476-4

Ejemplares similares

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021)

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
por: Buti, Maria, et al.
Publicado: (2021)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
por: Roade, Luisa, et al.
Publicado: (2023)

The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
por: Aceituno, Laia, et al.
Publicado: (2022)

ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype
por: Roade, Luisa, et al.
Publicado: (2022)

Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
por: Cortese, Maria Francesca, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection
por: Riveiro-Barciela, Mar, et al.
Publicado: (2014)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
por: Palom, Adriana, et al.
Publicado: (2022)

Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
por: Riveiro-Barciela, Mar, et al.
Publicado: (2021)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
por: Caballero, Andrea, et al.
Publicado: (2015)

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
por: Casillas, Rosario, et al.
Publicado: (2018)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
por: Homs, Maria, et al.
Publicado: (2016)

Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection
por: Godoy, Cristina, et al.
Publicado: (2019)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy
por: González, Carolina, et al.
Publicado: (2018)

Estimation of Alert and Change Limits of Haematological Quantities and its Application in the Plausibility Control
por: Sánchez-Navarro, Lourdes, et al.
Publicado: (2014)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management
por: Grau-López, Lara, et al.
Publicado: (2021)

Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19
por: Vargas‐Accarino, Elena, et al.
Publicado: (2022)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
por: Riveiro-Barciela, Mar, et al.
Publicado: (2023)

Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
por: Garcia-Garcia, Selene, et al.
Publicado: (2021)

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020
por: Bes, Marta, et al.
Publicado: (2022)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
por: Bermejo, Sheila, et al.
Publicado: (2022)

Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection
por: Costafreda, Maria I., et al.
Publicado: (2023)

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain
por: Palom, Adriana, et al.
Publicado: (2023)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
por: García-García, Selene, et al.
Publicado: (2022)

Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
por: Cortese, Maria Francesca, et al.
Publicado: (2021)

Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo
por: Purroy, Noelia, et al.
Publicado: (2014)

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals
por: Pons, Mònica, et al.
Publicado: (2017)

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
por: Pacin-Ruiz, Beatriz, et al.
Publicado: (2022)

Autoimmune hepatitis diagnosed after COVID-19 vaccination. Results from the spanish registry for autoimmune and cholestatic hepatitis
por: Barreira, Ana, et al.
Publicado: (2022)

Hepatitis C in Haematological Patients
por: Hwang, Y. Y., et al.
Publicado: (2010)

Electronic health record alerts enhance mass screening for chronic hepatitis B
por: Chak, Eric, et al.
Publicado: (2020)

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient
por: Gregori, Josep, et al.
Publicado: (2022)

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
por: Quer, Josep, et al.
Publicado: (2010)

Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for Management
por: Riveiro-Barciela, Mar, et al.
Publicado: (2022)

ZAP-70 Promotes the Infiltration of Malignant B-Lymphocytes into the Bone Marrow by Enhancing Signaling and Migration after CXCR4 Stimulation
por: Calpe, Eva, et al.
Publicado: (2013)

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells
por: Purroy, Noelia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f2isl6pno5ckus3rmjkt2e8dj8